INS and metabolic syndrome: This is counterintuitive owing to the progressive weight gain and increase in circulating levels of insulin, lipids, and inflammatory markers in the patients and the well-known association of low bacterial richness and adiposity, insulin resistance, dyslipidemia, and inflammatory phenotypes18.